The Merck Co-pay Assistance Program
Merck
OpenVerified·Apr 24, 2026
- Covers
- financial assistance
- Max award
- $25,000
- Enrollment cycle
- rolling
Eligibility
Eligible patients must be U.S. residents with private insurance covering KEYTRUDA for an FDA-approved indication. The program excludes individuals with government-funded insurance and requires patients to pay the first $25 of their co-pay per administration.
Apply
Application goes directly to Merck. RxCopays does not receive compensation.
Go to application →Status source
ENROLL NOW
Rare-disease support beyond financial help
This grant covers 9 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: